Skip to content

Clinical Study on the Application of Lidocaine Combined with Low-dose Esketamine Anesthesia Protocol in Gynecological Surgery

Clinical Study on the Application of Lidocaine Combined with Low-dose Esketamine Anesthesia Protocol in Gynecological Surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067951
Enrollment
Unknown
Registered
2023-02-01
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteromyoma

Interventions

Group 1:Lidocaine 1.5mg/kg, ketamine 0.25mg/kg
Group 2:sufentanil 0.3ug/kg

Sponsors

Yichang Central People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-50 years old; 2. ASA grade I-II; 3. Estimated anesthesia operation time <= 240 min; 4. The patient himself or the legally authorized person signs the informed consent.

Exclusion criteria

Exclusion criteria: 1. Body mass index (BMI): BMI >= 30 kg/m2 or upper limit of normal value); liver function impairment (ALT and or AST > 1.5 times upper limit of normal value); 10. Abnormal breath-hold test; 11. Patients with a history of severe head trauma and intracranial hypertension within 6 months; 12. Patients with mental or neurological diseases, or patients who cannot express their wishes correctly; 13. Patients with a history of taking sedative and analgesic drugs or monoamine oxidase inhibitors for a long time; 14. Expected surgical blood loss is greater than 100 mL; 15. Those who have participated in other drug clinical trials in the past month; 16. Patients who cannot perform ASA or FLACC scoring due to various reasons; 17. With other conditions, the investigator believes that the patients are not suitable for inclusion

Design outcomes

Primary

MeasureTime frame
Postoperative sore throat score;

Secondary

MeasureTime frame
Extubation time;Waking hours;Degree of sedation;Hemodynamic changes after intubation;Number of cases using m-hydroxylamine;Number of atropine use cases;Number of postoperative nausea and vomiting cases;Time to recovery of bowel function;Quality of postoperative recovery;

Countries

China

Contacts

Public ContactGong Yuan

Yichang Central People's Hospital

gy-yc@163.com+86 13986746821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026